News
A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored. Subscribe to our newsletter for the latest sci-tech news ...
A hospital in Surrey says it is the first NHS trust in the UK to use a "revolutionary" new device that improves prostate cancer surgery and reduces the need for radiotherapy. The Histolog Scanner ...
TipRanks on MSN
Orthocell Expands Remplir’s Use in Prostate Cancer Surgeries
Orthocell Ltd ( ($AU:OCC) ) just unveiled an announcement. Orthocell Ltd has announced the use of its nerve repair device, Remplir, in ...
Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or the "Company") is pleased to announce its flagship nerve repair device, Remplir, has been introduced to Urologists in Australia ...
OXFORD, UK / ACCESS Newswire / September 8, 2025 / Fine Treatment , a UK-based medical company, has unveiled new clinical ...
Transrectal ultrasound guided (TRUS) biopsy has been the gold standard for prostate cancer diagnosis, but carries a significant risk of urinary tract infection, sometimes requiring hospital admission ...
A hospital in Surrey says it is the first NHS trust in the UK to use a "revolutionary" new device that improves prostate cancer surgery and reduces the need for radiotherapy.
Globally Significant Opportunity Emerges as Remplir is used in Nerve-Sparing Prostate Cancer Surgery
Potential to reduce the risk of erectile dysfunction and urinary incontinence PERTH, Australia, Sept. 16, 2025 /PRNewswire/ --Regenerative medicine company Orthocell Limited (ASX:OCC, "Orthocell" or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results